Literature DB >> 1929580

Prevalence of anticardiolipin antibodies in juvenile chronic arthritis.

R Caporali1, A Ravelli, F De Gennaro, G Neirotti, C Montecucco, A Martini.   

Abstract

The prevalence of anticardiolipin antibodies was evaluated in 70 children with juvenile chronic arthritis (JCA), in 25 adult patients with rheumatoid arthritis, in 42 healthy children and in 40 adult controls. Thirty seven (53%) patients with JCA were positive for IgG or IgM anticardiolipin antibodies, or both, and 30 (43%) for IgG anticardiolipin antibodies. In contrast, only seven (28%) adult patients with rheumatoid arthritis presented anticardiolipin antibodies, which were of IgG class in four (16%) cases. IgG anticardiolipin antibodies were negative in all control subjects while IgM anticardiolipin antibodies were detected in two (5%) children and in four (10%) adult controls. No correlations were found in patients with JCA between the presence or titres of anticardiolipin antibodies and various clinical or laboratory variables. No patient with anticardiolipin antibodies showed any feature of the anticardiolipin syndrome.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1929580      PMCID: PMC1004500          DOI: 10.1136/ard.50.9.599

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  10 in total

1.  Enhanced interleukin 1 and depressed interleukin 2 production in juvenile arthritis.

Authors:  A Martini; A Ravelli; L D Notarangelo; R Maccario; A Lanfranchi; D Rondena; A G Ugazio; R Burgio
Journal:  J Rheumatol       Date:  1986-06       Impact factor: 4.666

Review 2.  Immunological abnormalities in juvenile chronic arthritis.

Authors:  A Martini
Journal:  Scand J Rheumatol Suppl       Date:  1987

3.  Anticardiolipin syndrome in childhood: a report of two cases.

Authors:  A Ravelli; R Caporali; E Bianchi; S Viola; M Solmi; C Montecucco; A Martini
Journal:  Clin Exp Rheumatol       Date:  1990 Jan-Feb       Impact factor: 4.473

4.  Antiphospholipid antibodies: a disease marker in 25 patients with antinuclear antibody negative systemic lupus erythematosus (SLE). Comparison with a group of 91 patients with antinuclear antibody positive SLE.

Authors:  O Meyer; J C Piette; P Bourgeois; P Fallas; O Bletry; P Jungers; M F Kahn; P Godeau; A Ryckewaert
Journal:  J Rheumatol       Date:  1987-06       Impact factor: 4.666

Review 5.  Hematological abnormalities associated with anticardiolipin antibodies.

Authors:  C Montecucco; M Longhi; R Caporali; F De Gennaro
Journal:  Haematologica       Date:  1989 Mar-Apr       Impact factor: 9.941

6.  The relationship of anticardiolipin antibodies to disease manifestations in pediatric systemic lupus erythematosus.

Authors:  W J Shergy; D W Kredich; D S Pisetsky
Journal:  J Rheumatol       Date:  1988-09       Impact factor: 4.666

7.  Thrombosis, recurrent fetal loss, and thrombocytopenia. Predictive value of the anticardiolipin antibody test.

Authors:  E N Harris; J K Chan; R A Asherson; V R Aber; A E Gharavi; G R Hughes
Journal:  Arch Intern Med       Date:  1986-11

Review 8.  Autoantibody profile in juvenile chronic arthritis.

Authors:  A M Leak
Journal:  Ann Rheum Dis       Date:  1988-03       Impact factor: 19.103

9.  Anti-phospholipid antibodies and thrombotic thrombocytopenic purpura.

Authors:  C Montecucco; M Di Lauro; E Bobbio-Pallavicini; M Longhi; R Caporali; F De Gennaro; E Ascari
Journal:  Clin Exp Rheumatol       Date:  1987 Oct-Dec       Impact factor: 4.473

10.  Venous thrombosis associated with lupus anticoagulant and anticardiolipin antibodies.

Authors:  P Pelkonen; O Simell; V Rasi; O Vaarala
Journal:  Acta Paediatr Scand       Date:  1988-09
  10 in total
  10 in total

Review 1.  Pediatric antiphospholipid syndrome.

Authors:  Cassyanne L Aguiar; Arzu Soybilgic; Tadej Avcin; Barry L Myones
Journal:  Curr Rheumatol Rep       Date:  2015-04       Impact factor: 4.592

Review 2.  The prevalence and clinical significance of antiphospholipid antibodies in rheumatoid arthritis.

Authors:  Ewa Olech; Joan T Merrill
Journal:  Curr Rheumatol Rep       Date:  2006-04       Impact factor: 4.592

3.  False negative results of anticardiolipin antibody test.

Authors:  S Kobayashi; M Tanaka; H Tsuda; H Hashimoto; S Hirose; T Saikawa; K Yoshida
Journal:  Ann Rheum Dis       Date:  1993-02       Impact factor: 19.103

4.  Pediatric APS: State of the Art.

Authors:  Arzu Soybilgic; Tadej Avcin
Journal:  Curr Rheumatol Rep       Date:  2020-03-03       Impact factor: 4.592

5.  Studies of the specificity and cross-reactions of antibodies to lipid A found in juvenile arthritis.

Authors:  J J Miller; L C Olds
Journal:  Clin Diagn Lab Immunol       Date:  1995-03

6.  Antiphospholipid antibody associated thrombosis in juvenile chronic arthritis.

Authors:  R Caporali; A Ravelli; B Ramenghi; C Montecucco; A Martini
Journal:  Arch Dis Child       Date:  1992-11       Impact factor: 3.791

7.  Anticardiolipin antibodies in children and adolescents with insulin-dependent diabetes mellitus.

Authors:  R Lorini; G d'Annunzio; C Montecucco; R Caporali; L Vitali; P Pessino; F Severi
Journal:  Eur J Pediatr       Date:  1995-02       Impact factor: 3.183

8.  Autoantibodies in chronic arthritis of childhood: relations with each other and with histocompatibility antigens.

Authors:  P N Malleson; M Y Fung; R E Petty; M J Mackinnon; M L Schroeder
Journal:  Ann Rheum Dis       Date:  1992-12       Impact factor: 19.103

Review 9.  Antiphospholipid antibodies in paediatrics.

Authors:  A Ravelli; A Martini; G R Burgio
Journal:  Eur J Pediatr       Date:  1994-07       Impact factor: 3.183

Review 10.  Pediatric Antiphospholipid Syndrome: from Pathogenesis to Clinical Management.

Authors:  Silvia Rosina; Cecilia Beatrice Chighizola; Angelo Ravelli; Rolando Cimaz
Journal:  Curr Rheumatol Rep       Date:  2021-01-28       Impact factor: 4.592

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.